2010 Conference Publication Characterization of cell lines from human malignant mesotheliomaRelan, V., Quinn, K. R., Tan, M. E., Wright, C. W., Clarke, B. E., Duhig, E. E., Yang, I. A., Fong, K. M. and Bowman, R. V. (2010). Characterization of cell lines from human malignant mesothelioma. The Thoracic Society of Australia & New Zealand (TSANZ) Annual Scientific Meeting 2010, Brisbane, Australia, 19-24 March 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2010.01736.x |
2009 Conference Publication Low-dose CT screening for lung cancer in Australia: QLCSS project interim reportMarshall, Henry M., Bowman, Rayleen, V, Crossin, Jane, Fuentes, Melanie, Slaughter, Richard, Zimmerman, Paul, Yang, Ian, Passmore, Linda, McCaul, Elizabeth, Redmond, Stanley and Fong, Kwun (2009). Low-dose CT screening for lung cancer in Australia: QLCSS project interim report. 13th World Conference on Lung Cancer, San Francisco, CA, United States, July 31-August 4 2009 . Philadelphia, PA United States: Lippincott Williams & Wilkins. |
2008 Conference Publication Regulation of hedgehog signaling pathway genes in lung cancerRelan, V., Chiang, N., Bowman, R. and Fong, K. (2008). Regulation of hedgehog signaling pathway genes in lung cancer. 20th Annual Lorne Cancer Conference, Lorne, Australia, 12-14 February 2008. |
2006 Conference Publication Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptorsMolenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC. |
2005 Conference Publication Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotypeKim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1 |
2005 Conference Publication P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epitheliumBowman, R., MacLachlan, R., Clarke, B., Duhig, E., Davidson, M. and Fong, K. (2005). P-239 Phosphorylation status of the retinoblastoma protein inpreneoplastic bronchial epithelium. Abstract of the 11th World Conference on Lung Cancer, Barcelona, Spain, 3–6 July 2005. Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80733-0 |
2005 Conference Publication Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomasLarsen, J., Pavey, S., Passmore, L., Bowman, R., Hayward, N., Zimmerman, P. and Fong, K. (2005). Expression profiling of metastatic recurrence in primary bronchogenic squamous cell carcinomas. 11th World Conference on Lung Cancer, Barcelona, Spain, 03-06 July 2005. Shannon, Co. Clare, Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80568-9 |
2005 Conference Publication Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokersBowman, R., Maclachlan, R., Clarke, B., Duhig, E. and Fong, K. (2005). Key molecular markers of proliferation, cell cycling and survival map topographically to areas of abnormal morphology, but do not predict occurrence of bronchial preneoplasia in smokers. 11th World Conference on Lung Cancer, Barcelona, Spain, 3rd – 6 July, 2005. CLARE: ELSEVIER IRELAND LTD. doi: 10.1016/S0169-5002(05)80385-X |
2005 Conference Publication Expression profiling of metastatic recurrence in primary bronchogenic squamous cellLarsen, J., Pavey, S., Passmore, L., Bowman, R., Hayward, N., Zimmerman, P. and Fong, K. (2005). Expression profiling of metastatic recurrence in primary bronchogenic squamous cell. 11th World Conference on Lung Cancer 2005, Barcelona, Spain, 3-6 July 2005. Ireland: Elsevier. doi: 10.1016/S0169-5002(05)80568-9 |
2005 Conference Publication Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003Fong, K., Bowman, R., Abraham, R., Windsor, M., Pratt, G., Fielding, D., Armstrong, J. and Zimmerman, P. (2005). Queensland Integrated Lung Cancer Outcomes Project (QILCOP): 2000 – 2003. 11th World Conference on Lung Cancer, Barcelona, Spain, 3–6 July, 2005. Shannon, Co. Clare, Ireland: Elsevier Science. doi: 10.1016/S0169-5002(05)80820-7 |
2002 Conference Publication The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atriumMolenaar, P., Russell, F. D., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L. and West, M. J. (2002). The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium. American Heart Association Scientific Sessions 2002, Chicago, 17-20 Nov, 2002. Hagerstown, U.S.A.: Lippincott Williams & Wilkins. |
1999 Conference Publication b2 adrenergic receptor genotypes in severe asthmaDouglas, J. A., Yang, I., Rabnott, G. C., Tunnicliffe, A. M., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenergic receptor genotypes in severe asthma. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science. |
1999 Conference Publication Quantification of pulmonary emphysema using high-resolution computed tomographyYang, I., Slaughter, R., Roszkowski, A., Fong, K. M. and Zimmerman, P. V. (1999). Quantification of pulmonary emphysema using high-resolution computed tomography. Heart and Lungs., Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science. |
1999 Conference Publication GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD)Yang, I. A., Gan, R., Tunnicliffe, A. M., Rabnott, G. C., Slaughter, R., Zimmerman, P.V. and Fong, K. M. (1999). GSTM1 and GSTP1 polymorphisms in chronic obstructive pulmonary disease (COPD). Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld.. |
1999 Conference Publication FHIT expression in non-small cell lung cancer: Correlation with LOH at 3p14, other genetic abnormalities and clinico-pathologic featuresGeradts, J., Minna, J.D., Zimmerman, P.V. and Fong, K. (1999). FHIT expression in non-small cell lung cancer: Correlation with LOH at 3p14, other genetic abnormalities and clinico-pathologic features. In: , , (13A-13A). . |
1999 Conference Publication b2 adrenoceptor genotypes and life-threatening asthmaRabnott, G. C., Tunnicliffe, A. M., Yang, I. A., Douglas, J. A., Shaw, J., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenoceptor genotypes and life-threatening asthma. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld.. |
1999 Conference Publication GSTM1 genotypes in Australian patients with NSCLCGan, R., Yang, I., Tunnicliffe, A. M., Rabnott, G. C., Bowman, R., Zimmerman, P.V. and Fong, K. M. (1999). GSTM1 genotypes in Australian patients with NSCLC. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science. |
1999 Conference Publication GSTM1 and GSTT1 genotypes in Australians with NSCLCGan, R., Yang, I. A., Tunnicliffe, A. M., Rabnott, G. C. and Fong, K. M. (1999). GSTM1 and GSTT1 genotypes in Australians with NSCLC. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society. |
1999 Conference Publication GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patientsYang, I. A., Gan, R., Tunniclife, A. M., Rabnott, G. C., Zimmerman, P.V. and Fong, K. M. (1999). GSTT1 and GSTM1 polymorphisms in Australian chronic obstructive pulmonary disease (COPD) patients. European Society Annual Congress, Madrid, Spain, 9 - 13 Oct, 1999. Copenhagen, Denmark: European Respiratory Society & Munksgaard Int. Publishers. |
1999 Conference Publication Correlation of FHIT expression with LOH at 3p14, other genetic abnormalities and clinical features in non-small cell lung cancer (NSCLC)Geradts, J., Minna, J.D., Zimmerman, P.V. and Fong, K. (1999). Correlation of FHIT expression with LOH at 3p14, other genetic abnormalities and clinical features in non-small cell lung cancer (NSCLC). In: , , (183A-183A). . |